Sopharma AD (SPH)
Market Closed
20 Jul, 14:50
WSE 
NYSE Primary WSE zł
7. 56
0
0%
zł
- Market Cap
12.21 P/E Ratio
1.3% Div Yield
24 Volume
1.93 Eps
zł 7.56
Previous Close Want to track SPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.52 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.33 |
| | | - | 0.09 |
| | | - | 0.27 |
| | | - | 0.18 |
| | | - | - |
| | | - | - |
| | | - | 0.29 |
| | | - | 0.15 |
| | | - | 0 |
| | | - | 0.03 |
SPH Earnings Reports FAQ
What is the earnings per share (EPS) for SPH?
The current EPS is 1.93.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately 31.41%, reflecting the SPH's performance and WSE market conditions.
When is the next earnings release date?
Sopharma AD has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Sopharma AD are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for SPH at this time, as Sopharma AD has no recent EPS data to calculate it.
